The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

NEW − You Helped Secure More Support of Increased Research Funding! You helped the pancreatic cancer community take a big step forward in securing increased federal funding for research! Thanks to ...

Pancreatic cancer is expected to become the second leading cause of cancer-related deaths in the U.S. before 2030, according to new projections published by PanCAN and its partners.

American Cancer Society’s Cancer Facts & Figures 2023 reports that the five-year survival rate for pancreatic cancer has increased to 12%, progress that PanCAN’s initiatives helped to fuel.

Learn about the common symptoms of the world’s toughest cancer, such as weight loss, digestive problems, back pain and more.

Itchy skin (with jaundice) can be a symptom of pancreatic cancer. Itching can also be a side effect of treatment. Get information on pancreatic cancer-related itching and ways to relieve it.

Dr. Brett Sheppard calls on healthcare leaders to engage with Native American and Alaska Native communities to improve the pancreatic cancer survival rate and the quality of life of patients.

Discover the five fruits recommended for pancreatic cancer patients by senior clinical dietitian at MD Anderson Cancer Center, Maria Petzel.

For the third year in the row, the pancreatic cancer five-year survival rate has increased one percentage point, to 13%, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report.

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers key insights from ASCO GI 2025.

For the first time in more than 10 years, the FDA has approved a new first-line treatment, called NALIRIFOX, for patients with metastatic pancreatic cancer.

About 20 percent of patients are eligible for surgery at diagnosis. Learn more about the types of surgery, such as the Whipple, and the importance of molecularly profiling the tumor tissue.